Thursday, August 25, 2016 7:15:41 AM
GlobeNewswire•August 25, 2016
•Total EDAP revenue up 20.4% year-over-year in the first six months of 2016
•Continued growth in HIFU system sales and treatment-driven revenue with strong margins
•Focal One® 510k under FDA review
•Solid cash position at €21.9 million as of June 30, 2016
https://finance.yahoo.com/news/edap-reports-69-growth-hifu-110000475.html
Beat estimates. Maybe a year ahead of schedule as far as what analysts were thinking.
conference call info...
EDAP to Report Second Quarter 2016 Financial Results on August 25, 2016
GlobeNewswire•August 11, 2016
LYON, France, Aug. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the second quarter ended June 30, 2016 on Thursday, August 25, 2016, during pre-market hours.
Company management will host a conference call on Thursday, August 25, 2016 at 8:30 a.m. ET to discuss the results and provide an update on recent business developments, including the sales of Ablatherm® Robotic HIFU in United States. To participate in the call, please dial 1-888-348-6419 in the U.S., or 1-412-902-4235 internationally. The conference ID number is 10091258. A live webcast of the conference call will be available on the investor relations page of the Company’s corporate website at www.edap-tms.com.
After the live event, the webcast will remain available on EDAP’s website through September 27, 2016. In addition, a dial-in replay of the call will be available until September 3, 2016. The telephone replay can be accessed by calling 1-877-870-5176 in the U.S. or 1-858-384-5517 internationally. Please use event passcode 10091258.
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Recent EDAP News
- U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading • IH Market News • 03/27/2024 10:57:08 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 01:15:12 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/02/2024 02:41:45 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/02/2024 01:10:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/07/2023 01:10:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/09/2023 11:05:38 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/24/2023 10:42:21 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM